Cellectis S.A. (LON:0WA2)
2.705
-0.035 (-1.26%)
At close: Sep 15, 2025
Cellectis Revenue
Cellectis had revenue of $18.19M USD in the quarter ending June 30, 2025, with 91.44% growth. This brings the company's revenue in the last twelve months to $63.44M, up 223.09% year-over-year. In the year 2024, Cellectis had annual revenue of $49.22M with 435.37% growth.
Revenue (ttm)
$63.44M
Revenue Growth
+223.09%
P/S Ratio
3.76
Revenue / Employee
$285.76K
Employees
222
Market Cap
174.20M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 49.22M | 40.02M | 435.37% |
Dec 31, 2023 | 9.19M | -16.53M | -64.26% |
Dec 31, 2022 | 25.72M | -12.87M | -33.35% |
Dec 31, 2021 | 38.60M | -20.97M | -35.20% |
Dec 31, 2020 | 59.56M | 36.57M | 159.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Shell | 198.54B |
Unilever | 51.24B |
Rolls-Royce Holdings | 19.54B |
British American Tobacco p.l.c. | 25.60B |
Rio Tinto Group | 39.22B |
BP p.l.c. | 134.89B |